Broker Regulation

"The House Oversight and Accountability Committee is shining a light on this issue in the health care system and will continue to examine solutions to make prescription drugs more affordable for all Americans," says Rep. James Comer.

Benefits advisors and brokers need to understand price transparency from the participant and provider perspectives, the compliance mandates new federal regulations aim to achieve, and most importantly, what strategies benefits professionals can take to optimize their role and value.

Renewal of the state's contract to procure specialty pharmacy prescriptions, which was set to take effect May 1, was halted after the pharmacy chain announced its refusal to sell mifepristone in 20 states.

Helping to understand the federal government's FCA enforcement priorities, as well as the priorities that private insurers should be contemplating.

New transparency rules are generating vast amounts of pricing information; however, the health care industry is finding that while collecting data is one thing, making sense of it can be something else entirely

Together, the Pregnant Workers Fairness Act and the PUMP Act place new requirements on employers with 15 or more employees to accommodate workers, including many exempt employees.